Characteristics of HIV-Tat protein transduction domain
- PMID: 15650690
Characteristics of HIV-Tat protein transduction domain
Abstract
The human immunodeficiency virus type 1 (HIV-1) Tat protein transduction domain (PTD), which contains rich arginine and lysine residues, is responsible for the highly efficient transduction of protein through the plasma membrane. In addition, it can be secreted from infected cells and has the ability to enter neighboring cells. When the PTD of Tat is fused to proteins and exogenously added to cells, the fusion protein can cross plasma membranes. Recent reports indicate that the endogenously expressed Tat fusion protein can demonstrate biodistribution of several proteins. However, intercellular transport and protein transduction have not been observed in some studies. Therefore, this study examined the intercellular transport and protein transduction of the Tat protein. The results showed no evidence of intercellular transport (biodistribution) in a cell culture. Instead, the Tat fusion peptides were found to have a significant effect on the transduction and intercellular localization properties. This suggests that the HIV-1 PTD passes through the plasma membrane in one direction.
Similar articles
-
HIV-1 TAT protein transduction domain mediates enhancement of enzyme prodrug cancer gene therapy in vitro: a study with TAT-TK-GFP triple fusion construct.Int J Oncol. 2005 Jul;27(1):203-8. Int J Oncol. 2005. PMID: 15942661
-
Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis.Biochemistry. 2003 Aug 5;42(30):9185-94. doi: 10.1021/bi0346805. Biochemistry. 2003. PMID: 12885253
-
Heparin binding by the HIV-1 tat protein transduction domain.Protein Sci. 2001 Oct;10(10):2138-9. doi: 10.1110/ps.23401. Protein Sci. 2001. PMID: 11567105 Free PMC article.
-
Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.Adv Drug Deliv Rev. 2005 Feb 28;57(4):579-96. doi: 10.1016/j.addr.2004.10.005. Epub 2004 Dec 19. Adv Drug Deliv Rev. 2005. PMID: 15722165 Review.
-
TAT-mediated protein transduction into mammalian cells.Methods. 2001 Jul;24(3):247-56. doi: 10.1006/meth.2001.1186. Methods. 2001. PMID: 11403574 Review.
Cited by
-
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.Nat Med. 2011 Jun 5;17(7):822-9. doi: 10.1038/nm.2345. Nat Med. 2011. PMID: 21642979 Free PMC article.
-
Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity.Mol Ther. 2011 May;19(5):903-12. doi: 10.1038/mt.2010.283. Epub 2010 Dec 21. Mol Ther. 2011. PMID: 21179011 Free PMC article.
-
Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.Cardiovasc Res. 2015 Jun 1;106(3):432-42. doi: 10.1093/cvr/cvv129. Epub 2015 Apr 13. Cardiovasc Res. 2015. PMID: 25870184 Free PMC article.
-
Protective Effects of a Jellyfish-Derived Thioredoxin Fused with Cell-Penetrating Peptide TAT-PTD on H2O2-Induced Oxidative Damage.Int J Mol Sci. 2023 Apr 16;24(8):7340. doi: 10.3390/ijms24087340. Int J Mol Sci. 2023. PMID: 37108504 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources